Laurion Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-154,068
| Closed | -$14.4M | – | 483 |
|
|
2022
Q1 | $14.4M | Buy |
+154,068
| New | +$14.4M | 0.18% | 33 |
|
|
2016
Q3 | – | Sell |
-173,300
| Closed | -$7.88M | – | 683 |
|
|
2016
Q2 | $7.88M | Buy |
+173,300
| New | +$7.88M | 0.12% | 59 |
|
|
2014
Q3 | – | Sell |
-28,600
| Closed | -$424K | – | 248 |
|
|
2014
Q2 | $424K | Sell |
28,600
-67,300
| -70% | -$998K | 0.01% | 95 |
|
|
2014
Q1 | $1.54M | Buy |
+95,900
| New | +$1.54M | 0.06% | 50 |
|